Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase 1 and Phase 2 Clinical Trials of Agents for Cancer Prevention
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Core - Development Funds
Dosage Forms and Delivery Systems for Antuniv
Clin Ctr Clin Trial/Observational Study of Whi
Caring for the Chronically Ill: Philadelphia 1945-1965
Regulation of Substrate Assimilation in the Newborn Infant
Recently added grants:
Risk factors associated with the prevalence of Peri-Implantitis disease
Defining the genetic landscape of nanophthalmos and the role of MYRF
Neuroscientific Exploration of Cultural Protective Factors in American Indians
Passive mobile sensing and machine learning for the detection of drinking episodes
Resolving differences between clinical opioids at single neurons
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN35000-8-0-1
Application #
7579487
Study Section
Project Start
2003-09-30
Project End
2008-09-29
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Phase 1 and Phase 2 Clinical Trials of Agents for Cancer Prevention
/ Mayo Clinic, Rochester
$2,258,000
NIH 2007
N01 CA
Phase 1 and Phase 2 Clinical Trials of Cancer Chemopreventive Agents
Limburg, Paul J. /
$2,257,713
NIH 2007
N01 CA
Phase 1 and Phase 2 Clinical Trials of Agents for Cancer Prevention
/
Comments
Be the first to comment on this grant